Publication | Open Access
Brain Cholinergic Markers and Tau Phosphorylation are Altered in Experimental Type 1 Diabetes: Normalization by Electroacupuncture
21
Citations
31
References
2013
Year
Neurophysiological BiomarkersNeurochemical BiomarkersSocial SciencesExperimental Type 1Alzheimer's DiseaseTau PhosphorylationDiabetic NeuropathyNeurologyBrain Cholinergic MarkersNeuropathologyNeurochemistryBrain Cholinergic SystemInsulin ManagementNeuroprotectionNervous SystemBrain Cholinergic DysfunctionNeurophysiologyDementiaDiabetesPhysiologyNerve Growth FactorNeuroscienceElectrophysiologyMolecular NeurobiologyDiabetes MellitusMedicine
Diabetes often correlates with tau phosphorylation and the development of Alzheimer's disease. Both are associated with brain cholinergic dysfunction that could benefit from nerve growth factor (NGF)-based therapies. Electroacupuncture (EA) improves brain NGF availability and action. Here we assessed the variations of NGF and tau phosphorylation in the cortex and hippocampus, as well as the expression of choline acetyltransferase in the basal forebrain following diabetes induction and EA in adult rats. We found that EA counteracts diabetes-associated tau hyperphosphorylation and decreases in NGF and choline acetyltransferase, suggesting a possible beneficial effect of EA on brain cholinergic system in diabetes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1